Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Health outcome measures"'
Publikováno v:
BJPsych Open, Vol 7 (2021)
Background NHS Practitioner Health is the England wide programme providing mental health and addiction healthcare to doctors and dentists. Outcomes are assessed using five measures. Aims To contribute to a service evaluation of NHS Practitioner Heal
Externí odkaz:
https://doaj.org/article/a9559a25a4074207ba021ad1e100cc10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The History of the Family. An International Quarterly, 28(2), 309-338. ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
History of the Family 28 (2023) 2
History of the Family, 28(2), 309-338
History of the Family 28 (2023) 2
History of the Family, 28(2), 309-338
Adult height is a remarkably accurate summary of early-life environmental conditions. Because of that, height may be negatively associated with mortality. These relationships – between early-life conditions and height, and between height and mortal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec3e451755be5ed8bec15ab6ba650b4a
https://doi.org/10.1080/1081602x.2022.2046125
https://doi.org/10.1080/1081602x.2022.2046125
Publikováno v:
Frontiers in Pharmacology, Vol 6 (2015)
The increase of non-communicable diseases at all ages has fostered the general concern for sustaining population health worldwide. Unhealthy lifestyles and dietary habits impacting physical and psycho-social health are well known risk factors for dev
Externí odkaz:
https://doaj.org/article/1b4092259147468c885e70d6f5f67e33
Publikováno v:
BJPsych Open
Background NHS Practitioner Health is the England wide programme providing mental health and addiction healthcare to doctors and dentists. Outcomes are assessed using five measures. Aims To contribute to a service evaluation of NHS Practitioner Healt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d8197f314de08a4f8636be34c88c71c
https://doi.org/10.1192/bjo.2021.926
https://doi.org/10.1192/bjo.2021.926
Publikováno v:
Neuro Oncol
INTRODUCTION Although diffuse gliomas of oligodendrocytic lineage demonstrate chemosensitivity, the survival outcomes associated with single- (i.e. temozolomide; TMZ) or multi-agent (i.e. PCV) chemotherapy regimens remain uncertain for anaplastic oli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aedd4eaa6d064e5591524aadaad0256c
https://europepmc.org/articles/PMC6847176/
https://europepmc.org/articles/PMC6847176/
Autor:
Anita Huttner, Jennifer Moliterno, Evgeniya Tyrtova, E. Zeynep Erson-Omay, Robert K. Fulbright, Lan Jin, Yawei Zhang, Elena I Fomchenko, Amy Y Zhao
Publikováno v:
Neuro Oncol
INTRODUCTION Vestibular schwannomas (VS) are known to be slow-growing lesions that can present significant issues for patients. Here, we sought to better understand their outcomes and risks for recurrence. METHODS We retrospectively reviewed clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c28e9133b2116c40363827ac645fc0e6
https://europepmc.org/articles/PMC6846905/
https://europepmc.org/articles/PMC6846905/
Autor:
Jimin Wu, Michael Youssef, Jacob Mandel, Ethan B. Ludmir, John DeGroot, Mary Frances McAleer, Akash R. Patel, Ali Jalali, Jeffrey M. Treiber
Publikováno v:
Neuro Oncol
BACKGROUND Optimal care for elderly patients with glioblastoma (GBM) remains in question due to their exclusion from and underrepresentation in clinical trials (including EORTC 22981) as well as their historically-poor overall survival. METHODS Retro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::054224d747cdebce0f2ae6efa9e4b066
https://europepmc.org/articles/PMC6847515/
https://europepmc.org/articles/PMC6847515/
HOUT-05. COMPARING OUTCOMES OF ADULT DIFFUSE MIDLINE GLIOMAS TO GLIOBLASTOMA (GBM) IN YOUNG PATIENTS
Autor:
Sasmit Sarangi, Eric T. Wong
Publikováno v:
Neuro Oncol
Diffuse midline gliomas are a diagnostic entity with astrocytic tumors in a midline location and in the pediatric age group they have been associated with poor outcomes. There is ongoing debate if adults with diffuse midline gliomas also have a poor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2336ef82e9d0c66d32a4910ee8bb1155
https://europepmc.org/articles/PMC6847124/
https://europepmc.org/articles/PMC6847124/
Autor:
Michael Drumm, Karan Dixit, Sean Grimm, Priya Kumthekar, Rimas Lukas, Jeffrey Raizer, Kwok-Ling Kam, Matthew McCord, Sean Sachdev, Timothy Kruser, Alicia Steffens, Rodrigo Javier, Kathleen McCortney, Craig Horbinski
Publikováno v:
Neuro Oncol
BACKGROUND Progress in extending the survival of glioblastoma (GBM) patients has been slow, suggesting that preclinical and clinical trial approaches may not fully take into account the nature of this cancer. A better understanding of why GBM patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc63954429c8481d7636d52a8c2766ef
https://europepmc.org/articles/PMC6847675/
https://europepmc.org/articles/PMC6847675/